Skip to main content

Table 2 Associations of Bisphenols with total CVD risk in US adults 2013–2016

From: The bisphenol F and bisphenol S and cardiovascular disease: results from NHANES 2013–2016

Variables Model 1 Model 2 Model 3
OR (95% CI) P OR (95% CI) P OR (95% CI) P
Bisphenol S
T1 1.00 1.00 1.00 1.00 1.00 1.00
T2 0.89 (0.40, 1.99) 0.767 0.97 (0.42, 2.24) 0.941 0.98 (0.44, 2.20) 0.956
T3 1.37( 0.80, 2.35) 0.240 1.96 (1.12, 3.40) 0.019* 1.99 (1.16, 3.40) 0.014**
P for trend   0.236   0.014*   0.011*
Bisphenol F
T1 1.00 1.00 1.00 1.00 1.00 1.00
T2 1.57 (0.88, 2.78) 0.120 1.72 (0.93, 3.20) 0.083 1.69 (0.88, 3.27) 0.111
T3 1.54 (0.82, 2.89) 0.174 1.72 (0.82, 3.61) 0.142 2.02 (0.86, 4.72) 0.101
P for trend   0.197   0.173   0.121
Bisphenol A
 T1 1.00 1.00 1.00 1.00 1.00 1.00
 T2 0.51 (0.27, 0.96) 0.039 0.63 (0.30, 1.32) 0.095 0.66 (0.33, 1.30) 0.218
 T3 0.69 (0.40, 1.20) 0.180 0.63(0.27, 1.46) 0.272 0.65 (0.29, 1.45) 0.283
 P for trend   0.185   0.264   0.273
  1. Model 1: unadjusted model
  2. Model 2: adjusted for urine creatinine, sex, age, race, education level, PIR, physical activity, alcohol drinking status, smoking status, BMI, blood pressure, and diabetes
  3. Model 3: adjusted for urine creatinine, sex, age, race, education level, PIR physical activity, alcohol drinking status, smoking status, BMI, blood pressure, diabetes, LDL-C, and energy intake; * p< 0.05;  ** p< 0.01; *** p< 0.001. The bold values indicate statistically significant differences